Margareth Dalcolmo Selected Research

Margareth Dalcolmo Research Topics

4	Tuberculosis (Tuberculoses) 02/2024 - 01/2016
4	COVID-19 04/2023 - 10/2021
3	Extensively Drug-Resistant Tuberculosis 04/2018 - 01/2017
2	Pulmonary Tuberculosis 02/2024 - 01/2016
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2017 - 09/2016
1	Hypertension (High Blood Pressure) 02/2024
1	Infections 02/2024
1	Herpes Labialis (Fever Blister) 10/2023
1	Disease Progression 01/2023
1	Cicatrix (Scar) 01/2023
1	Lung Diseases (Lung Disease) 07/2018
1	Substance-Related Disorders (Drug Abuse) 07/2018
1	Coinfection 07/2018
1	Body Weight (Weight, Body) 01/2017
1	HIV Infections (HIV Infection) 01/2012
1	Alcoholism (Alcohol Abuse) 01/2012

4	BCG Vaccine FDA Link 02/2024 - 01/2023
3	VaccinesIBA 02/2024 - 01/2023
3	Ethambutol (Myambutol)FDA LinkGeneric 07/2018 - 01/2012
3	Pyrazinamide FDA LinkGeneric 01/2017 - 01/2012
2	COVID-19 VaccinesIBA 01/2023 - 01/2023
2	Moxifloxacin (Avelox)FDA Link 07/2018 - 01/2016
2	Streptomycin (Streptomycin Sulfate)FDA Link 07/2018 - 01/2012
2	bedaquiline (R207910)IBA 07/2017 - 01/2017
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2016 - 01/2012
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2016 - 01/2012
1	GoldIBA 02/2024
1	Levofloxacin (Levaquin)FDA Link 07/2018
1	OPC-67683IBA 07/2017
1	Clofazimine (Lamprene)FDA Link 01/2017
1	Oxygen (Dioxygen)IBA 09/2016
1	GasesIBA 09/2016
1	rifapentine (Priftin)FDA Link 01/2016
1	Antitubercular AgentsIBA 01/2016
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2012